Published in J Pain Symptom Manage on October 29, 2010
Case-mix adjusted hospital mortality is a poor proxy for preventable mortality: a modelling study. BMJ Qual Saf (2012) 0.90
The Business Case for Palliative Care: Translating Research Into Program Development in the U.S. J Pain Symptom Manage (2015) 0.86
Exclusion of palliative care from hospital mortality rates: not ready for prime time. J Pain Symptom Manage (2010) 0.78
Use of inpatient palliative care services in patients with metastatic incurable head and neck cancer. Head Neck (2015) 0.75
Impact of computerized provider order entry (CPOE) on length of stay and mortality. J Am Med Inform Assoc (2017) 0.75
Analyzing hospital mortality rates and palliative care. J Pain Symptom Manage (2010) 0.75
Validation of the V66.7 Code for Palliative Care Consultation in a Single Academic Medical Center. J Palliat Med (2016) 0.75
A Nationwide Analysis of Outcomes of Weekend Admissions for Intracerebral Hemorrhage Shows Disparities Based on Hospital Teaching Status. Neurohospitalist (2015) 0.75
Palliative care coding practices in Canada since the introduction of guidelines and the HSMR indicator. BMJ Open (2015) 0.75
Racial Differences in Palliative Care Use After Stroke in Majority-White, Minority-Serving, and Racially Integrated U.S. Hospitals. Crit Care Med (2017) 0.75
Palliative Care for Hospitalized Patients With Stroke: Results From the 2010 to 2012 National Inpatient Sample. Stroke (2017) 0.75
The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol (2012) 7.54
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol (2012) 7.16
American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol (2003) 6.66
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol (2009) 4.95
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med (2004) 4.84
American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol (2011) 4.64
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol (2006) 4.61
Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med (2008) 4.25
Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J Biol Chem (2009) 4.05
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2007) 3.91
Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol (2006) 3.71
Palliative care for frail older adults: "there are things I can't do anymore that I wish I could . . . ". JAMA (2006) 3.63
Early specialty palliative care--translating data in oncology into practice. N Engl J Med (2013) 3.58
Clinical practice. Palliative care. N Engl J Med (2004) 3.45
The role of chemotherapy at the end of life: "when is enough, enough?". JAMA (2008) 3.31
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. J Clin Oncol (2011) 3.21
Starch catabolism by a prominent human gut symbiont is directed by the recognition of amylose helices. Structure (2008) 3.02
The growth of palliative care programs in United States hospitals. J Palliat Med (2005) 3.00
Pediatric palliative care. N Engl J Med (2004) 2.94
Palliative care consultation teams cut hospital costs for Medicaid beneficiaries. Health Aff (Millwood) (2011) 2.77
The shortage of essential chemotherapy drugs in the United States. N Engl J Med (2011) 2.74
Palliative care and oncology partnerships in real practice. Oncology (Williston Park) (2011) 2.72
The symptom burden of chronic critical illness. Crit Care Med (2004) 2.66
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2012) 2.62
Talking with patients about dying. N Engl J Med (2012) 2.34
'I don't want Jenny to think i'm abandoning her': views on overtreatment. Health Aff (Millwood) (2014) 2.14
Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med (2003) 2.11
Lung cancer in railroad workers exposed to diesel exhaust. Environ Health Perspect (2004) 2.06
Providing pain and palliative care education internationally. J Support Oncol (2011) 2.04
Lung cancer and elemental carbon exposure in trucking industry workers. Environ Health Perspect (2012) 2.04
Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing. J Clin Oncol (2009) 2.03
Identifying patients in need of a palliative care assessment in the hospital setting: a consensus report from the Center to Advance Palliative Care. J Palliat Med (2010) 2.02
Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control (2003) 1.86
Is it time for (survivorship care) plan B? J Clin Oncol (2011) 1.84
Residential exposure to petrochemicals and the risk of leukemia: using geographic information system tools to estimate individual-level residential exposure. Am J Epidemiol (2006) 1.84
Advances in microbicide vaginal rings. Antiviral Res (2010) 1.76
SPIKE$: a six-step protocol for delivering bad news about the cost of medical care. J Clin Oncol (2008) 1.76
Palliative care and the quality of life. J Clin Oncol (2011) 1.75
Spatial modeling of PM10 and NO2 in the continental United States, 1985-2000. Environ Health Perspect (2009) 1.73
Fatal Loeffler's endocarditis due to hypereosinophilic syndrome. Am J Hematol (2007) 1.73
Palliative care in the treatment of advanced heart failure. Circulation (2009) 1.72
The association of particulate air metal concentrations with heart rate variability. Environ Health Perspect (2002) 1.71
Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem (2010) 1.68
America's care of serious illness: a state-by-state report card on access to palliative care in our nation's hospitals. J Palliat Med (2011) 1.66
Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem (2006) 1.64
The effect of a social work intervention to enhance advance care planning documentation in the nursing home. J Am Geriatr Soc (2005) 1.62
Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin (2013) 1.62
Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol (2012) 1.60
Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. Transplantation (2004) 1.59
Lung cancer and vehicle exhaust in trucking industry workers. Environ Health Perspect (2008) 1.57
Methods for constructing and assessing propensity scores. Health Serv Res (2014) 1.54
The national agenda for quality palliative care: the National Consensus Project and the National Quality Forum. J Pain Symptom Manage (2007) 1.53
Improving the quality of cancer care: implications for palliative care. J Palliat Med (2014) 1.49
Structure of antibody-neutralized murine norovirus and unexpected differences from viruslike particles. J Virol (2007) 1.49
Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol (2006) 1.48
High rates of advance care planning in New York City's elderly population. Arch Intern Med (2004) 1.46
When critical illness becomes chronic: informational needs of patients and families. J Crit Care (2005) 1.46
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol (2004) 1.44
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys (2005) 1.43
'Futile care': what to do when your patient insists on chemotherapy that likely won't help. Oncology (Williston Park) (2008) 1.42
Moving upstream: a review of the evidence of the impact of outpatient palliative care. J Palliat Med (2013) 1.42
Advance Care Planning Discussions: Why They Should Happen, Why They Don't, and How We Can Facilitate the Process. Oncology (Williston Park) (2015) 1.40
Integrating palliative care into the PICU: a report from the Improving Palliative Care in the ICU Advisory Board. Pediatr Crit Care Med (2014) 1.39
A case of inaccurate prognostication after the ARCTIC protocol. J Pain Symptom Manage (2012) 1.39
The association between personal measurements of environmental exposure to particulates and heart rate variability. Epidemiology (2002) 1.38
Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Antimicrob Agents Chemother (2011) 1.38
An antibody to the putative aphid recognition site on cucumber mosaic virus recognizes pentons but not hexons. J Virol (2002) 1.35
Differential antifungal and calcium channel-blocking activity among structurally related plant defensins. Plant Physiol (2004) 1.35
Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives. J Clin Oncol (2009) 1.30
Structural determinants of metal specificity in the zinc transport protein ZnuA from synechocystis 6803. J Mol Biol (2003) 1.30
Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. J Pain Symptom Manage (2011) 1.29
Long-term ambient multipollutant exposures and mortality. Am J Respir Crit Care Med (2010) 1.29
Historical estimation of diesel exhaust exposure in a cohort study of U.S. railroad workers and lung cancer. Cancer Causes Control (2006) 1.26
Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. J Virol (2012) 1.21
The big chill--inserting the DEA into end-of-life care. N Engl J Med (2006) 1.20
Cause-specific mortality in the unionized U.S. trucking industry. Environ Health Perspect (2007) 1.20
Reforming care for persons near the end of life: the promise of quality improvement. Ann Intern Med (2002) 1.20
A brief targeted review of susceptibility factors, environmental exposures, asthma incidence, and recommendations for future asthma incidence research. Environ Health Perspect (2006) 1.20
SusG: a unique cell-membrane-associated alpha-amylase from a prominent human gut symbiont targets complex starch molecules. Structure (2010) 1.20
Summary of the findings from the exposure assessments for metalworking fluid mortality and morbidity studies. Appl Occup Environ Hyg (2003) 1.19
High-resolution cryo-electron microscopy structures of murine norovirus 1 and rabbit hemorrhagic disease virus reveal marked flexibility in the receptor binding domains. J Virol (2010) 1.19
Novel inhibitors complexed with glutamate dehydrogenase: allosteric regulation by control of protein dynamics. J Biol Chem (2009) 1.17
An intravaginal ring for the simultaneous delivery of multiple drugs. J Pharm Sci (2012) 1.17
Mold prevention strategies and possible health effects in the aftermath of hurricanes and major floods. MMWR Recomm Rep (2006) 1.14
Human rhinovirus capsid dynamics is controlled by canyon flexibility. Virology (2003) 1.14
Skin exposure to isocyanates: reasons for concern. Environ Health Perspect (2006) 1.14
High-resolution x-ray structure and functional analysis of the murine norovirus 1 capsid protein protruding domain. J Virol (2010) 1.13
Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques. Antimicrob Agents Chemother (2012) 1.11
The structure of a cyanobacterial bicarbonate transport protein, CmpA. J Biol Chem (2006) 1.11
Structural studies on ADP activation of mammalian glutamate dehydrogenase and the evolution of regulation. Biochemistry (2003) 1.10
Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings. AIDS (2012) 1.10
Comparison of fine particle measurements from a direct-reading instrument and a gravimetric sampling method. J Occup Environ Hyg (2004) 1.09
Does palliative care improve quality? A survey of bereaved family members. J Pain Symptom Manage (2008) 1.09
Wiser use of dose-dense adjuvant therapy in breast cancer. J Clin Oncol (2012) 1.09
Expression, purification and characterization of human glutamate dehydrogenase (GDH) allosteric regulatory mutations. Biochem J (2002) 1.08
Structure of a SusD homologue, BT1043, involved in mucin O-glycan utilization in a prominent human gut symbiont. Biochemistry (2009) 1.08
Cotton dust and endotoxin levels in three Shanghai textile factories: a comparison of samplers. J Occup Environ Hyg (2006) 1.07